Article Details
Retrieved on: 2024-01-23 13:43:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca (AZ) has shared positive results from a late-stage study evaluating its immunotherapy Imfinzi (durvalumab) in a subset of patients ...
Article found on: www.pmlive.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here